TNFRSF19L / RELT antibody
Principal name
TNFRSF19L / RELT antibody
Alternative names for TNFRSF19L / RELT antibody
Tumor necrosis factor receptor superfamily member 19L, Receptor expressed in lymphoid tissues
Ncbi ID
9606, NP_116260, NP_116260.2, NP_689408, NP_796047.2, NM_152222, NM_032871
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunoprecipitation (IP), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of TNFRSF19L / RELT antibody
- Kit Component:
- - KN314660G1, Relt gRNA vector 1 in pCas-Guide vector
- KN314660G2, Relt gRNA vector 2 in pCas-Guide vector
- KN314660D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western blot analysis of TNFRSF19L over-expressed 293 cell line, cotransfected with TNFRSF19L Validated Chimera RNAi ( Cat # H00084957-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with TNFRSF19L monoclonal antibody (M01), clone 3F8 (Cat # H00084957-M01 ). GAPDH ( 36.1 kDa ) used as specificity and loading control.
Western Blot analysis of TNFRSF19L expression in transfected 293T cell line by TNFRSF19L monoclonal antibody (M01), clone 3F8.Lane 1: TNFRSF19L transfected lysate(46.1 KDa).Lane 2: Non-transfected lysate.
TNFRSF19L polyclonal antibody (A01), Lot # 051123JC01 Western Blot analysis of TNFRSF19L expression in HL-60 ( Cat # L014V1 ).
RELT MaxPab rabbit polyclonal antibody. Western Blot analysis of RELT expression in mouse kidney.
RELT MaxPab rabbit polyclonal antibody. Western Blot analysis of RELT expression in human pancreas.
Western Blot analysis of RELT expression in transfected 293T cell line (H00084957-T02) by RELT MaxPab polyclonal antibody.Lane 1: RELT transfected lysate(46.10 KDa).Lane 2: Non-transfected lysate.
RELT MaxPab rabbit polyclonal antibody. Western Blot analysis of RELT expression in HeLa.
Immunohistochemical analysis of RELT staining in human lymph node formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of RELT expression in HeLa (A); T47D (B); COLO205 (C) whole cell lysates.
Sample(30 ug whole cell lysate). A:HeLa S3. 10% SDS PAGE. TA308068 diluted at 1:1000
Immunohistochemical analysis of paraffin-embedded U87 xenograft , using RELT(TA308068) antibody at 1:100 dilution.
Immunofluorescence analysis of methanol-fixed A431, using RELT(TA308068) antibody at 1:200 dilution.
Western blot analysis of extracts from Jurkat cells, COLO205 cells, 293 cells and HepG2 cells, using TR19L antibody.The lane on the right is treated with the synthesized peptide.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA308068 | TNFRSF19L / RELT antibody |
||||||
| Rabbit Polyclonal antibody to RELT (RELT tumor necrosis factor receptor) | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€416.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
| TA315947 | TNFRSF19L / RELT antibody |
||||||
| Rabbit polyclonal anti-RELT (TR19L) antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| C11468-1 | TNFRSF19L / RELT antibody |
||||||
 |
Rabbit | Aff - Purified | Hu, Ms | E, WB |
50 µg /
€230.00
|
||
| Assay Biotech | |||||||
| C11468-2 | TNFRSF19L / RELT antibody |
||||||
|
Rabbit | Aff - Purified | Hu, Ms | E, WB |
0.1 mg /
€330.00
|
||
| Assay Biotech | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP721066 | TNFRSF19L / RELT (transcript variant 2) |
||||
| Purified recombinant protein of Human RELT tumor necrosis factor receptor (RELT), transcript variant 2 | |||||
 |
Human | > 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€139.00
|
|
| OriGene Technologies, Inc. | |||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC221786L2V | Lenti ORF particles, RELT (mGFP-tagged) - Human RELT tumor necrosis factor receptor (RELT), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC208642L2V | Lenti ORF particles, RELT (mGFP-tagged) - Human RELT tumor necrosis factor receptor (RELT), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC221786L1V | Lenti ORF particles, RELT (Myc-DDK tagged) - Human RELT tumor necrosis factor receptor (RELT), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
| RC208642L1V | Lenti ORF particles, RELT (Myc-DDK tagged) - Human RELT tumor necrosis factor receptor (RELT), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
